Heart Rate Variability Biofeedback for Female Sexual Arousal Disorder
Autonomic Imbalance and Female Sexual Arousal Disorder: The Identification of Heart Rate Variability Level as a Risk Factor and Treatment Target
1 other identifier
interventional
65
1 country
1
Brief Summary
Low resting heart rate variability (HRV) has been associated with sexual arousal problems and overall sexual dysfunction in women. Research has indicated that HRV biofeedback leads to increases in HRV as well as improvements in symptoms associated with several psychological disorders, some of which are comorbid with sexual arousal problems in women. Autogenic training also facilitates increases in HRV and was recently associated with acute increases in sexual arousal among sexually healthy women. The primary aim of the current study is to examine the efficacy of HRV biofeedback, with and without autogenic training, for the treatment of female sexual arousal disorder (FSAD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 31, 2016
CompletedFirst Posted
Study publicly available on registry
November 8, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedOctober 11, 2018
October 1, 2018
1.3 years
October 31, 2016
October 10, 2018
Conditions
Outcome Measures
Primary Outcomes (3)
Physiological sexual arousal assessed by vaginal photoplethysmography
One month
Subjective sexual arousal assessed by Film Scale (Heiman & Rowland, 1983)
One month
Sexual function assessed by Female Sexual Function Index (Rosen et al., 2000)
Two months
Secondary Outcomes (3)
Depression symptoms assessed by Beck Depression Inventory-II (Beck, Brown, & Steer, 1996)
Two months
Anxiety symptoms assessed by Beck Anxiety Inventory (Beck et al., 1988)
Two months
Interoceptive awareness assessed by the Multidimensional Assessment of Interoceptive Awareness (Mehling et al., 2012)
Two months
Study Arms (3)
HRV Biofeedback
EXPERIMENTALAt home HRV biofeedback using mobile device
HRV Biofeedback with Autogenic Training
EXPERIMENTALAt home HRV biofeedback using mobile device plus autogenic training recording
Wait List
NO INTERVENTIONWait list control
Interventions
At-home heart rate variability biofeedback using Elite HRV app and Polar H7 chest strap
Autogenic training recording provided on a CD
Eligibility Criteria
You may qualify if:
- Premenopausal (18-40 years)
- Fluent in English
- Heterosexual or bisexual
- Score of 26.55 or less on the Female Sexual Function Index (FSFI)
- Current sexual arousal dysfunction
- Ownership of an Elite HRV compatible device (recent iPhone, iPad, or Android)
You may not qualify if:
- Pregnant or breastfeeding
- History of or current sexually transmitted infections
- History of major pelvic surgery
- History of childhood sexual abuse
- Currently taking androgens, estrogens, or other medical treatments to enhance sexual arousal
- Current psychosis
- If on antidepressants or antihypertensives, must be stabilized for at least 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Texas at Austin
Austin, Texas, 78751, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cindy M Meston
The University of Texas at Austin
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 31, 2016
First Posted
November 8, 2016
Study Start
October 1, 2016
Primary Completion
January 1, 2018
Study Completion
January 1, 2018
Last Updated
October 11, 2018
Record last verified: 2018-10